Dashboard
Manage Tickers

ATR APTARGROUP, INC.

NYSE aptar.com


$ 114.22 $ 1.06 (0.94 %)    

Tuesday, 04-Nov-2025 15:59:54 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 114.18
$ 114.36
$ 111.86 x 32
$ 117.13 x 3
$ 112.53 - $ 116.00
$ 103.23 - $ 175.85
1,029,138
na
7.49B
$ 0.80
$ 17.87
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-02-2025 03-31-2025 10-Q
4 02-07-2025 12-31-2024 10-K
5 10-25-2024 09-30-2024 10-Q
6 07-26-2024 06-30-2024 10-Q
7 04-26-2024 03-31-2024 10-Q
8 02-09-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 07-28-2023 06-30-2023 10-Q
11 04-28-2023 03-31-2023 10-Q
12 02-17-2023 12-31-2022 10-K
13 10-28-2022 09-30-2022 10-Q
14 07-29-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-18-2022 12-31-2021 10-K
17 10-29-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-19-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-01-2020 03-31-2020 10-Q
24 02-24-2020 12-31-2019 10-K
25 11-01-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-21-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-03-2018 03-31-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 05-01-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 11-04-2016 09-30-2016 10-Q
38 08-01-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-aptargroup-lowers-price-target-to-133
Wells Fargo Maintains Overweight on AptarG...
11/03/2025 14:15:25

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and lowers the price target from $152 to $133.

baird-maintains-outperform-on-aptargroup-lowers-price-target-to-145
Baird Maintains Outperform on AptarGroup, ...
11/03/2025 12:35:06

Baird analyst Ghansham Panjabi maintains AptarGroup (NYSE:ATR) with a Outperform and lowers the price target from $160 to $145.

aptargroup-sees-q4-adj-eps-120-128-vs-143-est
AptarGroup Sees Q4 Adj EPS $1.20-$1.28 vs ...
10/30/2025 21:02:34

aptargroup-q3-adj-eps-162-beats-157-estimate-sales-961131m-beat-953508m-estimate
AptarGroup Q3 Adj. EPS $1.62 Beats $1.57 E...
10/30/2025 21:01:38

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

aptar-digital-health-announces-fda-has-granted-510k-clearance-for-herotracker-sense
Aptar Digital Health Announces FDA Has Gra...
10/16/2025 12:11:50

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U....

top-3-materials-stocks-that-may-rocket-higher-in-q3
Top 3 Materials Stocks That May Rocket Hig...
09/24/2025 12:22:06

aptargroup-increases-its-quarterly-dividend-from-045-to-048
AptarGroup Increases Its Quarterly Dividen...
09/08/2025 21:03:20

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies,...

this-hubspot-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This HubSpot Analyst Begins Coverage On A ...
09/04/2025 14:14:40

keybanc-initiates-coverage-on-aptargroup-with-overweight-rating-announces-price-target-of-220
Keybanc Initiates Coverage On AptarGroup w...
09/04/2025 09:42:05

Keybanc analyst Paul Knight initiates coverage on AptarGroup (NYSE:ATR) with a Overweight rating and announces Price Target ...

is-the-market-bullish-or-bearish-on-aptargroup
Is the Market Bullish or Bearish on AptarG...
08/27/2025 15:00:25

wells-fargo-maintains-overweight-on-aptargroup-lowers-price-target-to-153
Wells Fargo Maintains Overweight on AptarG...
08/04/2025 14:10:35

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and lowers the price target from $173 to $153.

raymond-james-maintains-outperform-on-aptargroup-lowers-price-target-to-172
Raymond James Maintains Outperform on Apta...
08/04/2025 13:22:27

Raymond James analyst Matt Roberts maintains AptarGroup (NYSE:ATR) with a Outperform and lowers the price target from $182 t...

aptargroup-sees-q3-adj-eps-153-161-vs-165-est
AptarGroup Sees Q3 Adj EPS $1.53-$1.61 vs ...
07/31/2025 21:02:03

AptarGroup (NYSE:ATR) is looking for Q3 Adj EPS of $1.53-$1.61 vs $1.65 analyst estimate..

aptargroup-q2-adj-eps-166-beats-157-estimate-sales-966009m-beat-954058m-estimate
AptarGroup Q2 Adj. EPS $1.66 Beats $1.57 E...
07/31/2025 21:00:58

AptarGroup (NYSE:ATR) reported quarterly earnings of $1.66 per share which beat the analyst consensus estimate of $1.57 by 5.87...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

what-to-expect-from-aptargroups-earnings
What to Expect from AptarGroup's Earnings
07/30/2025 16:01:36

how-do-investors-really-feel-about-aptargroup
How Do Investors Really Feel About AptarGr...
07/28/2025 19:00:30

atara-biotherapeutics-announces-fda-acceptance-and-priority-review-of-bla-for-tabelecleucel-in-epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease
Atara Biotherapeutics Announces FDA Accept...
07/24/2025 12:04:16

aptargroup-says-its-nasal-drug-delivery-system-was-used-in-recently-published-brain-imaging-study-from-wake-forest-university-school-of-medicine
AptarGroup Says Its Nasal Drug Delivery Sy...
07/23/2025 12:30:48

Research by Wake Forest University School of Medicine provides a crucial method for future Alzheimer's disease treatment tr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION